Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E FitzSimmons

Showing results (11-20 of 276) with videos related to

Pageof 28
Sort By:
Therapeutic Innovation & Regulatory Science|October 23, 2020
Ensuring Black Lives Matter in Drug DevelopmentWilliam E Fitzsimmons, Clara Okorie-Awé
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1997
Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolismM E Fitzsimmons, J M Collins
Transplantation|October 15, 1996
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantationR P Kershner, W E Fitzsimmons
Yonsei Medical Journal|January 1, 2005
FK778, a synthetic malononitrilamideWilliam E Fitzsimmons, M Roy First
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Pentamidine therapy in renal failure: case report and literature reviewW E Fitzsimmons, S S Luskin
Yonsei Medical Journal|January 1, 2005
Modified release tacrolimusM Roy First, William E Fitzsimmons
Transplantation|June 18, 2004
New drugs to improve transplant outcomesM Roy First, William E Fitzsimmons
Chemical Research in Toxicology|September 1, 1993
Fatty acid beta-oxidation-dependent bioactivation of halogenated thiaalkanoic acids in isolated rat hepatocytesM E Fitzsimmons, M W Anders
Clinical Pharmacy|November 1, 1986
Effect of serum separator tubes on phenytoin concentrationW E Fitzsimmons, W R Garnett
American Journal of Orthopedics (Belle Mead, N.J.)|July 16, 2010
Giant cell tumor at tibial screw site after anterior cruciate ligament reconstructionSean E Fitzsimmons, Noah Chinitz, Jonathan Glashow
Pageof 28

Showing results (11-20 of 276) with videos related to

Sort By:
Pageof 28
Therapeutic Innovation & Regulatory Science|October 23, 2020
Ensuring Black Lives Matter in Drug DevelopmentWilliam E Fitzsimmons, Clara Okorie-Awé
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1997
Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolismM E Fitzsimmons, J M Collins
Transplantation|October 15, 1996
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantationR P Kershner, W E Fitzsimmons
Yonsei Medical Journal|January 1, 2005
FK778, a synthetic malononitrilamideWilliam E Fitzsimmons, M Roy First
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Pentamidine therapy in renal failure: case report and literature reviewW E Fitzsimmons, S S Luskin
Yonsei Medical Journal|January 1, 2005
Modified release tacrolimusM Roy First, William E Fitzsimmons
Transplantation|June 18, 2004
New drugs to improve transplant outcomesM Roy First, William E Fitzsimmons
Chemical Research in Toxicology|September 1, 1993
Fatty acid beta-oxidation-dependent bioactivation of halogenated thiaalkanoic acids in isolated rat hepatocytesM E Fitzsimmons, M W Anders
Clinical Pharmacy|November 1, 1986
Effect of serum separator tubes on phenytoin concentrationW E Fitzsimmons, W R Garnett
American Journal of Orthopedics (Belle Mead, N.J.)|July 16, 2010
Giant cell tumor at tibial screw site after anterior cruciate ligament reconstructionSean E Fitzsimmons, Noah Chinitz, Jonathan Glashow
Pageof 28